9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
AstraZeneca
Incyte Corporation
Eli Lilly and Company
OHSU Knight Cancer Institute
Moscow Clinical Scientific Center
Gilead Sciences
City of Hope Medical Center
Rutgers, The State University of New Jersey